Corticosteroid Reduction in COPD

NCT02857842 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

318

Enrollment

OTHER

Sponsor class

Conditions

Lung Diseases, Obstructive
Blood Eosinophil Count
Glucocorticoids
COPD
Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Prednisolone

Sponsor

Chronic Obstructive Pulmonary Disease Trial Network, Denmark